Member Info for bigAl67

Yea could be Tuesday, but my thinking is Monday?

Much to look forward to:-

. Devote funding - £Value

. ''and other aligned funding.''? !!

. As well as: In-kind contributions - Details

. FDA Update

. Full validation of the stroke test

. Continued rollout of AHIL in the UK, then Europe, and the rest of the World.

. Notification of increased AIHL Test Sales.

. Continued working with the NHS, and how this will be scheduled.

. Notification of further new Products.

. Good Financial Position.

. Our SP rising.

All the above is IMHO !!

Correction should say ''on Monday 3rd July''

I am thinking we will see an announcement on Monday 3rd June of our 2nd £300,000 draw down, under the terms of the £5m Equity Prepayment Facility !!

Hi MyIPA,

Last year our Final Results for the year ending 30th June 2022 were delivered on the 21st November 2022.

Our half year ended 31st December 2022 and were delivered on 31st March 2023.

As far as I am aware we only receive Half year and Full year Final results, and therefore I do not expect to see our next results for the year ending today June 30th until November this year 2023 ?

yep of co**** you are a gdr shareholder - lol -

a reminder of your posts on the 20th june 2023 -

stockpickfree

posted in: gdr

posts: 337

price: 16.00

no opinion

re: time to buy!20 jun 2023 16:20

''the exact inverse is true. it’s still not too late to sell. although you’d have been better off doing so in the 20’s when i first started arguing this. this is going down to single figures under the pressure of rf’s constant selling.

you longs need to have a look at the sunk cost fallacy. because your “reasoning” here is illogical and fallacious.''

''the exact inverse is true. it’s still not too late to sell. although you’d have been better off doing so in the 20’s when i first started arguing this. this is going down to single figures under the pressure of rf’s constant selling.

you longs need to have a look at the sunk cost fallacy. because your “reasoning” here is illogical and fallacious.''

stockpickfree

posted in: gdr

posts: 337

price: 16.00

no opinion

re: missing persons alert20 jun 2023 11:02

''smart move..

you don’t catch a falling knife, you drop it and bind up the wound it caused you.

gdr will have it’s time in the sun at some future date. but stubbornly holding on as rf continues to dump is madness. buy back in when they have finished selling.''

He is a Very Peculiar Character -

When is a Recommendation - Not a Recommendation - Answer - When you have starres in your Eyes LOL

Just Recommended your last Post stephen11 !!! LOL

You are right starres - in my Native Language - when you mention an investment opportunity to your wife, and she Buys in - and you do not tell her not too - then this is considered to be a Recommendation LOL

For starres eyes only !!! LOL

RNS Number : 6932U

Genedrive PLC

30 March 2023

Genedrive® MT-RNR1 ID Test receives positive final recommendation by NICE

NICE issues final guidance for use in the NHS through Early Value Assessment programme

genedrive plc (AIM:GDR), the point of care molecular diagnostics company, announces that, further to the Company's announcement on 9 February 2023, the UK's National Institute for Health and Care Excellence (NICE) has today ratified and finalised its recommendation following a public consultation process that the Genedrive® MT-RNR1 ID Kit ''can be used by the NHS.''

NICE recommends CYP2C19 genotyping for clopidogrel treatment

RNS Number : 9399Z

Genedrive PLC

19 May 2023

Genedrive® CYP2C19 ID test modelled to be a clinically and cost-effective option

genedrive plc (AIM: GDR), the point of care molecular diagnostics company, announces that the UK's National Institute for Health and Care Excellence ("NICE") has recommended in draft guidance that CYP2C19 genotyping should be used before clopidogrel administration in the management of ischemic stroke ("IS") patients.

Looking Good !!

Reads like a Recommendation to me ?!!

LOL - so starres recommended GDR to his wife at an average SP of £1.90, and now she is his Ex-Wife - No wonder he is still hanging around here as a Non-Shareholder - that is an Almighty Grudge he is carrying - starres needs to realise it is his fault she left him, not GDR's LOL

The only Post that the Non-Shareholding starres seems to have got right, when he posted:-

''Lack of volume here going to become increasingly problematic for SP me thinks....''

Well our SP certainly has shown to be problematic today - to himself - LOL - UP 10.94% TODAY !!

Market Summary >

Genedrive PLC

17.75 GBX

+1.75 (10.94%)today

29 Jun, 16:30 BST

Thankfully it looks like all of Nathan91 Posts have been removed !!!

I do not believe that Idiot Nathan can read - (He is also posting his Rubbish on Multiple Bulletin Boards)

Where it states +1.50 (9.38%) - This means our SP is going UP - LOL

Market Summary >

Genedrive PLC

17.50 GBX

+1.50 (9.38%)today

29 Jun, 13:00 BST

LOL stockprickfree,

See's our SP is rising, and now says he is invested LOL

This is the post he posted on the 20th June - and he has only posted negatively towards our GDR since this post:-

stockpickfree

Posted in: GDR

Posts: 333

Price: 16.00

No Opinion

RE: Time to buy!20 Jun 2023 16:20

''The exact inverse is true. It’s still not too late to sell. Although you’d have been better off doing so in the 20’s when I first started arguing this. This is going down to single figures under the pressure of RF’s constant selling.

You longs need to have a look at the sunk cost fallacy. Because your “reasoning” here is illogical and fallacious.''

Thanks for Posting/sharing gunto2022 - much appreciated !!

Good Morning MyIPA,

Just the thought of them, gives me an Irritating Itch ''CRINGY''.

Our first £300,000 drawdown was announced on the 2nd June 2023.

So hopefully we will hear soon of the 2nd £300,000 drawdown, with a further circa £160,000 payment due to be paid to our Genedrive, on exercise of RF's second grant of warrants !!

''DEVOTE pulls together health economists, clinicians, informaticians, and researchers to quickly access new technologies, and provide feedback in an iterative fashion. Genedrive's CYP2C19 ID Kit is one of three exemplar projects to be included in the programme which is expected to be funded through the 'Innovate grant', 'in-kind contributions', 'and other aligned funding.''

. So Innovate Grant incoming !!

. ''and other aligned funding.'' !!

. As well as: In-kind contributions - which can include:-

. Voluntary labour (time or services ‘donated’ should be additional and not part of the persons' normal job).

. Donated equipment.

. Services donated from other companies or organisations.

. Use of premises or office space for the project.

The term “In-kind contribution” is described as non-financial assets that are being put at the disposal of a partnership and which can be used both in the context of external calls (e.g. a research infrastructure) or of in-kind activities (e.g. a dataset for use in a common R&I programme).

It was Good to see RF fund us with the first drawdown of £300,000, plus a further payment of £168,000 pounds for their grant of 682,730 warrants, at the Reference Price equating to 24.6071 pence!!

So a Total payment to our Genedrive of £468,000 pounds, and possibly somewhere near this same amount coming again soon ?!!

Looking forward to the DEVOTE funding announcement!!

We know that we spend circa £125,000 per product development per month, and we usually have two products in development at any one time.

So it will be interesting to see whether DEVOTE Funding will now cover this same level of development costing/products going forward?!!

If they do then I take it that means we will not need to fork out the £250,000 of Development costs each month - which in turn could reduce our Monthly running costs from £400,000 per month to £150,000 per month - now that would have a Great Positive impact on our financial situation?!!

We also know that 'Sales of our AIHL Test are going on in the Background' - Looking forward to hearing how well the Quantity is Growing?!!

Well this is how I see our position anyway !!

The above is all -- IMHO

Hi Jimi,

RF paid our Genedrive £168,000 for the 682,730 warrants they received from the £300,000 drawdown.

It seems to me RF are selling just the right amount of their shares to keep the SP as low as they can around the 17p level, but hold off from selling at a level that would take and keep the SP below 16p - they want to buy future warrants from future drawdowns - which means they need the SP to stay above 16p, in order that our Genedrive can drawdown further £300,000 monthly amounts.

I believe RF want the warrants, because they see our SP rising nicely, and RF will do very well from these warrants?!!

Well this is how I see it anyway!!!

The above is all -- IMHO

From the RNS:-

''Investors have been granted 682,730 warrants equal to 40% of this drawdown divided by the Reference Price of 17.57648 pence. The exercise price of the warrants payable to the Company will be 140% of the Reference Price equating to 24.6071 pence.''

So how does this work out:-

40% of this drawdown = 40% of £300,000 = 120,000, and 120,000 divided by the reference price of 17.57648 pence = 682,730 warrants

The exercise price of these 682,730 warrants is 140% of the reference price of 17.57648p = 140% x 17.57648 = 24.6071p payable to the company.

Therefore 682,730 warrants x 24.6071p = £168,000

Yep - I am Looking forward to the weeks ahead !!!